“…The 2,3-dihydro-4H-1,3-benzothiazin-4-one scaffold has shown a wide range of bioactivity, including antitumor (Li et al, 2012;Wang et al, 2015;Kamel et al, 2010;Nofal et al, 2014), antimicrobial (Popiolek et al, 2016;Mandour et al, 2007), antimalarial (Mei et al, 2013), HIV-RT inhibition (Jeng et al, 2015;Hou et al, 2016) and cyclooxygenase COX-2 enzyme inhibition (Zarghi et al, 2009). The S-oxides of these compounds have been little studied (a search found fewer than 50), despite the evidence of enhanced activity in the similar 2,3,5,6-tetrahydro-4H-1,3-thiazin-4-ones (Surrey et al, 1958;Surrey, 1963a,b) and 1,3-thiazolidin-4-ones (Gududuru et al, 2004).…”